Skip to main content
. 2017 Feb 21;1(4):237–246. doi: 10.1210/js.2016-1097

Table 3.

Patients With ≥3 Concurrent AEs Potentially Associated With Adrenal Insufficiency

Mifepristone (n = 833) Placebo (n = 627)
3 Concurrent AEsa 4 (0.48) 0
4 Concurrent AEsa 0 1 (0.16)
Totala 4 (0.48) 1 (0.16)
a

No significant differences (P <0.05) in AEs were noted between mifepristone and placebo groups, as assessed using Fisher’s exact test.